Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Clinical trial NCT07738276 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07738276
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-18
- Primary completion
- 2027-06-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.